Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving hydrolase
Reexamination Certificate
2007-06-05
2007-06-05
Nashed, Nashaat T. (Department: 1656)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving hydrolase
C435S019000
Reexamination Certificate
active
10633742
ABSTRACT:
HPTPbeta is useful as a target in screening agents effective for the treatment of angiogenesis mediated disorders.
REFERENCES:
patent: 6342219 (2002-01-01), Thorpe et al.
Huang et al. HCPTPA, a protein tyrosine phosphotase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity. J. Biol. Chem. 1999, 53, 38183-38188.
Wang, Y. et al., “Expressions and Characterization of Wild Type, Truncated, and Mutant Forms of the Intracellular Region of the Receptor-Like Protein Tyrosine Phosphatase HPTPβ”,The J. of biological Chem., 1992, Vo. 267, No. 23, pp.
Wright, M.B. et al., “Protein-Tyrosine Phosphatases in the Vessel Wall Differential Expression After Acute Arterial Injury”,Arterioscler Thromb Vasc., 2000, pp. 1189-1198.
Fachinger, G. et al., “Functional Interaction of Vascular Endothelial-Protein-Tyrosine Phosphatase with the angiopoietin Receptor Tie-2”,Oncogene,1999, vol. 18, pp. 5948-5953.
Gaits, F. et al., “Increase in Receptor-like Protein tyrosine Phosphatase Activity and Expression Level on Density-dependent Growth Arrest fo Endothelial Cells”,Biochem. J.,1995, vol. 311, pp. 97-103.
Harder, K.W. et al., “Characterization and kinetic analysis of the Intracellular domain of human protein tyrosine phosphatase β (HPTPβ) using synthetic phosphopeptides”,Biochem J.,1994, vol. 296, pp. 395-401.
Krueger, N.X. et al., “Structural diversity and evolution of human receptor-like protein tyrosine phosphatases”,The EMBRO J.,1990, vol. 9, No. 10, pp. 3241-3252.
Chanteau, S.H. et al., “Synthesis of Anthropomorphic Molecules: The NanoPutians,”J. Org. Chem.2003, vol. 68, pp. 8750-8766.
Hopkins, S.C. et al., “Inhibitors of Kinesin Activity from Structure-Based Computer Screening,”Biochemistry,2000, vol. 39, pp. 2805-2814.
Jones, G. et al., “Development and Validation of a Genetic Algorithm for Flexible Docking,”J. Mol. Biol.1997, vol. 267, pp. 727-748.
Martin, Y. C., “3D Database Searching in Drug Design,”J. of Medicinal Chemistry,1992, vol. 35, No. 12, pp. 2145-2154.
Rarey, M. et al., “A Fast Flexible Docking Method Using An Incremental Construction Algorithm,”J. Mol. Biol.,1996, vol. 261, pp. 470-489.
Skoichet, B.K. et al., “Lead Discovery Using Molecular Docking,”Chem. Biology,2002, vol. 6, pp. 439-446.
Stahl, M. et al., “Detailed Analysis of Scoring Functions for Virtual Screening,”J. Med. Chem.,2001, vol. 44, pp. 1035-1042.
U.S. Appl. No. 10/634,027, filed Aug. 4, 2003, Kevin G. Peters, et al.
Davis Michael Glen
Peters Kevin Gene
McMahon Mary Pat
Nashed Nashaat T.
Paul Andrew A.
The Procter & Gamble & Company
Upite David V.
LandOfFree
HPTPbeta as a target in treatment of angiogenesis mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HPTPbeta as a target in treatment of angiogenesis mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HPTPbeta as a target in treatment of angiogenesis mediated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3884740